TRANSPAN Webinar: Molecular mechanisms underlying resistance to therapies in PDAC

TRANSPAN Webinar: Molecular mechanisms underlying resistance to therapies in PDAC

We’re pleased to announce the launch of the TRANSPAN webinar series, aimed at sharing recent research and clinical developments, encouraging interdisciplinary collaboration, and supporting the training of early career researchers and clinicians. The webinars will take place monthly via Microsoft Teams,last one hour (30-45minutes of presentation and 15-30 minutes of discussion), and be recorded. Speakers—mainly TRANSPAN members—will offer both clinical and research-focused perspectives, with an emphasis on understanding PDAC in a clinical context and exploring translational advances. The first session will be on 22nd May. Certificates of attendance will be provided, and PhD students are especially encouraged to join, as the webinars can support their academic development and may count toward their university program records.

TOPIC: CLINICAL

Molecular mechanisms underlying resistance to therapies in PDACment and clinical translation

SPEAKER

  • Prof. Elisa Giovannetti

    Department of Medical Oncology, Amsterdam UMC, Vrije Universiteit

    Amsterdam, the Netherlands

     

    Cancer Pharmacology Lab, AIRC Start-Up Unit, Fondazione Pisana per la Scienza,

    Pisa, Italy

LINK